Skip the gray-market guesswork. A licensed clinician reviews your health history, a licensed U.S. pharmacy compounds your prescription, and a care team stays with you after it ships.
$243 / mo$270 as a single month · $648 for a 3-month supply
A licensed clinician reviews every request. If Thymosin Alpha-1 fits your health history, they write your prescription and your pharmacy takes it from there.
Requires an online medical evaluation. Prescribed only when a licensed provider determines it's appropriate.
Thymosin Alpha-1 has its own online clinical questionnaire — your history, medications, and goals.
A clinician reads your history and takes the time to get it right before anything is prescribed.
Compounded for your prescription and shipped cold-chain, with care-team check-ins after.
Thymosin Alpha-1 is easy to find online and hard to trust there. Promise works the way medicine is supposed to work — a clinician decides, a licensed pharmacy fills, and someone stays accountable to you.
Prescribed for you specifically, after a real look at your health history — never pulled off a shelf.
Your prescription is compounded for you by a licensed U.S. pharmacy — not a mystery vial from an unregulated website.
Temperature-safe shipping, follow-up check-ins, and a care team that answers — before and after your medication arrives.
The peptide is a fragment of prothymosin alpha, and research interest centers on how it participates in the maturation of T cells and in signaling between the innate and adaptive arms of the immune system.
Thymosin Alpha-1 has been approved in a number of countries outside the United States for certain uses. In the United States it is not FDA-approved, and it is supplied here as a compounded medication.
A licensed provider reads your history, decides whether Thymosin Alpha-1 fits it, and sets the protocol.
The thymus is the gland where T cells learn their job, and it shrinks steadily from adolescence onward. Thymosin Alpha-1 is one of the peptides that gland produces — 28 amino acids, cleaved from a larger precursor protein called prothymosin alpha — and it is the compound behind most of the serious research on thymic peptides.
Promise offers it one way only: a licensed provider reviews your health history and prescribes it only when treatment is appropriate for you.
Thymosin Alpha-1 was isolated from thymus tissue in the 1970s and has been synthesized ever since. In the body it is one fragment of prothymosin alpha, and it circulates as part of the signaling traffic between immune cells rather than acting as a structural component of anything.
It anchors our immune support category. It also has an unusually long research history for a compounded peptide: it has been studied in human trials in a number of clinical settings, and it has been approved in several countries outside the United States for certain uses. That history is worth knowing, and it is also worth being precise about what it does and does not mean for what we supply, which is covered below.
The research reads Thymosin Alpha-1 as a modulator rather than a stimulant. Work in this area looks at how the peptide interacts with receptors on immune cells — toll-like receptors in particular — and at how that interaction feeds into the maturation and differentiation of T cells in the thymus.
From there the studied effects branch into the signaling molecules immune cells use to talk to each other, and into the relationship between the innate immune system, which responds fast and generically, and the adaptive system, which responds slowly and specifically. Modulation is the operative word. The interest is in how the peptide participates in these conversations, not in turning any part of the system up.
Mechanism is not outcome. A described pathway tells you what researchers are examining; it does not tell you what happens in a given person, and this page is not the place to pretend otherwise.
Thymosin Alpha-1 has been approved in a number of countries outside the United States for certain uses. In the United States it is not FDA-approved, and the version available through Promise is a compounded medication prepared by a licensed U.S. pharmacy against a prescription written for you specifically.
Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality. Approval elsewhere does not change that, and we do not treat the two as interchangeable. What it does mean is that clinicians outside the United States have worked with the compound for a long time, and that the body of published human research is larger than for most peptides in this catalog.
Everything starts with an intake questionnaire built specifically for this compound: your health history, current medications, and what you are trying to address. A licensed provider reads it. If Thymosin Alpha-1 is a reasonable fit for your history, they write the prescription and set the protocol. If it is not, they decline, and they will say so.
A peptide that acts on immune signaling deserves particular care. Autoimmune conditions, immune-modifying medications, transplant history, and active illness are all things a provider weighs before deciding, and any one of them can make this the wrong choice.
If you are prescribed, your medication is compounded and dispensed by a licensed U.S. pharmacy, and shipped in discreet, temperature-safe packaging. Dosing is not a number to find online; your provider sets the protocol from your evaluation, and you follow theirs.
After that it is check-ins. Your care team follows up, and anything that needs to change, changes with a clinician involved. Thymosin Alpha-1 belongs on top of the fundamentals — sleep, nutrition, movement, vaccination decisions made with your own doctor — rather than in place of them. It is one support among several for the promise you already made to yourself.
Thymosin Alpha-1 is a peptide of 28 amino acids, cleaved from a larger precursor protein called prothymosin alpha and produced by the thymus — the gland where T cells mature. Research interest centers on its role in that maturation process and on how it modulates signaling between the innate and adaptive immune systems. It has been studied in humans more extensively than most compounded peptides, though the published work sits in specific clinical settings rather than in general use.
Yes. Thymosin Alpha-1 is available through Promise only by prescription. You complete an intake questionnaire, a licensed provider reviews your health history, and they prescribe only when treatment is appropriate for you.
No. Thymosin Alpha-1 is not FDA-approved in the United States, even though it has been approved in a number of other countries for certain uses. What we supply is a compounded medication, and compounded medications are not reviewed by the FDA for safety, effectiveness, or quality. It is prepared by a licensed U.S. compounding pharmacy against a prescription written for you specifically, after a licensed provider has reviewed your health history.
You start with the intake form for Thymosin Alpha-1, which is its own clinical questionnaire covering your health history, medications, and goals. A licensed provider reviews your answers and prescribes only if Thymosin Alpha-1 is appropriate for you. If it is, your medication is compounded and dispensed by a licensed U.S. pharmacy and shipped in temperature-safe packaging, with follow-up check-ins from your care team.
Mechanism, mostly. Studies examine how Thymosin Alpha-1 interacts with receptors on immune cells, how it participates in the maturation and differentiation of T cells, and how it influences the signaling molecules those cells use to communicate. Immune modulation is not the same as immune enhancement, and none of this describes an outcome in any individual person. A provider considering this peptide is considering your whole history — including any autoimmune condition or immune-modifying medication, which can make it a poor fit.